Physician profile
James Ringler
NPI 1871581355
$98,191.68
in general payments reported to CMS, 2019-2025
12 companies · $1,878 in 2025
The $1,878 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,822 · 2020: $17K · 2021: $14.98 · 2022: $43K · 2023: $23K · 2024: $11K · 2025: $1,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Food and Beverage: $1,704 · Travel and Lodging: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,071.54 |
| Food and Beverage | $1,703.68 |
| Travel and Lodging | $1,428.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $73,375.35 | 2019-2024 | |
| Smith+Nephew, INC. | $20,924.41 | 2019-2022 | |
| Carbofix Orthopedics INC | $1,669.83 | 2020-2025 | |
| Catalyst Orthoscience | $1,500.00 | 2025 | |
| Zimmer Biomet Holdings, INC. | $354.88 | 2024 | Tapestry, A.L.P.S. |
| Depuy Synthes Sales INC. | $159.01 | 2025 | Tfn-Advance, Na |
| Curvafix, INC. | $88.00 | 2024 | Curvafix Im Implant |
| Radius Health, INC. | $52.52 | 2019-2023 | Tymlos |
| Abbott Laboratories | $25.88 | 2025 | Proclaim |
| Solventum Corporation | $15.00 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Pacira Therapeutics, INC. | $13.94 | 2020 | |
| Fx Shoulder Solutions, INC | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ringler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.